David M. Knott Jr’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

David M. Knott Jr’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,000	Closed	-$207K	–	179
2022 Q4	$207K	Hold	18,000	–	–	0.08%	75
2022 Q3	$207K	Hold	18,000	–	–	0.09%	91
2022 Q2	$207K	Hold	18,000	–	–	0.09%	90
2022 Q1	$207K	Hold	18,000	–	–	0.07%	95
2021 Q4	$207K	Buy	+18,000	New	+$10.2K	0.07%	90

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

David M. Knott Jr's IBER.WS Position: Q1 2023 in Review

David M. Knott Jr sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 18,000 shares — an estimated $207K sold.

David M. Knott Jr first reported a position in IBER.WS in Q4 2021 and held it in 5 quarters. The position peaked at $207K in Q4 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

David M. Knott Jr reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
David M. Knott Jr sold 18,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $207K.
David M. Knott Jr first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
David M. Knott Jr's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $207K in Q4 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on David M. Knott Jr's 13F filing for Q1 2023, filed 11 May 2023.